1
Enquiry period
with 28.05.2024 17:06
to 07.06.2024 10:00
2
Bidding period
with 07.06.2024 10:00
to 13.06.2024 14:00
3
Auction
14.06.2024 15:00
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 788 148,15 MDL
Period of clarifications: 28 May 2024, 17:06 - 7 Jun 2024, 10:00
Submission of proposals: 7 Jun 2024, 10:00 - 13 Jun 2024, 14:00

Supplier technical support:

(+373) 79999801

Advertising
Advertising

“Achiziționarea medicamentelor necesare pentru realizarea Programului Național de Combatere a Hepatitelor virale B, C și D, pentru anul 2024, suplimentar, repetat 1”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
28 May 2024, 16:54
Date modified
28 May 2024, 17:06
Achizitii.md ID
21231343
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Advertising
Documents of the procurement procedure
DUAE Model
Bidding Documents
DUAE Model
28.05.24 17:06
contract model nou
Bidding Documents
contract model nou
28.05.24 17:06
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
28.05.24 17:06
Propunerea financiară
Technical Specifications
Propunerea financiară
28.05.24 17:06
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
28.05.24 17:06
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
28.05.24 17:06
Documentatia standard.signed
Bidding Documents
Documentatia standard.signed
28.05.24 17:06
Anunt de participare.signed
Bidding Documents
Anunt de participare.signed
28.05.24 17:06
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
28.05.24 17:06
Propunerea tehnică
Technical Specifications
Propunerea tehnică
28.05.24 17:06
Only authorized platform users may ask questions during the clarification period.